,sentence,sent_id,sent_begin,firstCharEnt1,lastCharEnt1,entity1,chunk1,firstCharEnt2,lastCharEnt2,entity2,chunk2,relation
1,Viral gene expression may be reactivated by stimulation of the cells with LPS or cytokines such as TNF-alpha in vitro.,1,94,0,9,non_Protein,Viral gene,99,107,Protein,TNF-alpha,O
12,"Exposure of monocytic cells to bacterial lipopolysaccharide (LPS) activates the NF-kappa B/Rel family of proteins and leads to the rapid induction of inflammatory gene products, including tissue factor (TF).",12,1985,188,200,Protein,tissue factor,203,204,Protein,TF,O
15,This nuclear complex was activated by LPS with kinetics that preceded induction of the TF gene.,15,2453,5,19,non_Protein,nuclear complex,87,88,Protein,TF,Subunit-Complex
21,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,22,30,Protein,TNF-alpha,100,122,non_Protein,DNA-binding heterodimer,O
22,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,22,30,Protein,TNF-alpha,124,133,non_Protein,NF-kappa B,O
23,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,22,30,Protein,TNF-alpha,136,142,non_Protein,p50/p65,O
24,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,22,30,Protein,TNF-alpha,163,179,non_Protein,specific sequence,O
25,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,22,30,Protein,TNF-alpha,188,211,non_Protein,HIV-long terminal repeat,O
26,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,100,122,non_Protein,DNA-binding heterodimer,124,133,non_Protein,NF-kappa B,Subunit-Complex
27,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,100,122,non_Protein,DNA-binding heterodimer,136,142,non_Protein,p50/p65,Subunit-Complex
28,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,100,122,non_Protein,DNA-binding heterodimer,163,179,non_Protein,specific sequence,O
29,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,100,122,non_Protein,DNA-binding heterodimer,188,211,non_Protein,HIV-long terminal repeat,O
30,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,124,133,non_Protein,NF-kappa B,136,142,non_Protein,p50/p65,Subunit-Complex
31,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,124,133,non_Protein,NF-kappa B,163,179,non_Protein,specific sequence,O
32,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,124,133,non_Protein,NF-kappa B,188,211,non_Protein,HIV-long terminal repeat,O
33,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,136,142,non_Protein,p50/p65,163,179,non_Protein,specific sequence,O
34,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,136,142,non_Protein,p50/p65,188,211,non_Protein,HIV-long terminal repeat,O
35,"The effect of LPS and TNF-alpha is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the HIV-long terminal repeat.",2,213,163,179,non_Protein,specific sequence,188,211,non_Protein,HIV-long terminal repeat,O
36,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,71,73,Protein,CR1,76,79,Protein,CD35,O
37,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,71,73,Protein,CR1,86,88,non_Protein,CR3,O
38,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,71,73,Protein,CR1,91,100,non_Protein,CD11b/CD18,O
39,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,76,79,Protein,CD35,86,88,non_Protein,CR3,O
40,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,76,79,Protein,CD35,91,100,non_Protein,CD11b/CD18,O
41,The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in HIV-infected human monocytic cells.,3,427,86,88,non_Protein,CR3,91,100,non_Protein,CD11b/CD18,Subunit-Complex
42,Stimulation of CR1 or CR3 induces a two- to fourfold increase in the amount of cell-associated and released p24 Ag in cell cultures that was equivalent to that observed in control cultures triggered with LPS.,5,811,15,17,Protein,CR1,22,24,non_Protein,CR3,O
43,Stimulation of CR1 or CR3 induces a two- to fourfold increase in the amount of cell-associated and released p24 Ag in cell cultures that was equivalent to that observed in control cultures triggered with LPS.,5,811,15,17,Protein,CR1,108,113,Protein,p24 Ag,O
44,Stimulation of CR1 or CR3 induces a two- to fourfold increase in the amount of cell-associated and released p24 Ag in cell cultures that was equivalent to that observed in control cultures triggered with LPS.,5,811,22,24,non_Protein,CR3,108,113,Protein,p24 Ag,O
45,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,40,42,Protein,CR1,47,49,non_Protein,CR3,O
46,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,40,42,Protein,CR1,88,97,non_Protein,NF-kappa B,O
47,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,40,42,Protein,CR1,99,105,non_Protein,p50/p65,O
48,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,47,49,non_Protein,CR3,88,97,non_Protein,NF-kappa B,O
49,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,47,49,non_Protein,CR3,99,105,non_Protein,p50/p65,O
50,We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells.,6,1020,88,97,non_Protein,NF-kappa B,99,105,non_Protein,p50/p65,Subunit-Complex
51,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,17,26,non_Protein,NF-kappa B,28,34,non_Protein,p50/p65,Subunit-Complex
52,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,17,26,non_Protein,NF-kappa B,79,81,Protein,CR1,O
53,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,17,26,non_Protein,NF-kappa B,86,88,non_Protein,CR3,O
54,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,28,34,non_Protein,p50/p65,79,81,Protein,CR1,O
55,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,28,34,non_Protein,p50/p65,86,88,non_Protein,CR3,O
56,Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from HIV-seronegative donors.,7,1146,79,81,Protein,CR1,86,88,non_Protein,CR3,O
57,TNF-alpha did not mediate the translocation of NF-kappa B p50/p65 induced by triggering of complement receptors.,9,1416,0,8,Protein,TNF-alpha,47,56,non_Protein,NF-kappa B,O
58,TNF-alpha did not mediate the translocation of NF-kappa B p50/p65 induced by triggering of complement receptors.,9,1416,0,8,Protein,TNF-alpha,58,64,non_Protein,p50/p65,O
59,TNF-alpha did not mediate the translocation of NF-kappa B p50/p65 induced by triggering of complement receptors.,9,1416,47,56,non_Protein,NF-kappa B,58,64,non_Protein,p50/p65,Subunit-Complex
60,"Taken together, these observations suggest that HIV gene expression may be activated in infected monocytes through interaction of the cells with complement-opsonized particles and that enhanced viral replication is associated with C3 receptor-mediated nuclear translocation of the NF-kappa B complex.",10,1529,48,55,non_Protein,HIV gene,231,232,non_Protein,C3,O
61,"Taken together, these observations suggest that HIV gene expression may be activated in infected monocytes through interaction of the cells with complement-opsonized particles and that enhanced viral replication is associated with C3 receptor-mediated nuclear translocation of the NF-kappa B complex.",10,1529,48,55,non_Protein,HIV gene,281,298,non_Protein,NF-kappa B complex,O
62,"Taken together, these observations suggest that HIV gene expression may be activated in infected monocytes through interaction of the cells with complement-opsonized particles and that enhanced viral replication is associated with C3 receptor-mediated nuclear translocation of the NF-kappa B complex.",10,1529,231,232,non_Protein,C3,281,298,non_Protein,NF-kappa B complex,O
63,Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.,11,1830,32,49,non_Protein,tissue factor gene,107,128,non_Protein,c-Rel/p65 heterodimers,O
64,Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.,11,1830,32,49,non_Protein,tissue factor gene,135,151,non_Protein,kappa B-like site,O
65,Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.,11,1830,107,128,non_Protein,c-Rel/p65 heterodimers,135,151,non_Protein,kappa B-like site,O
66,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,41,55,non_Protein,nuclear complex,100,116,non_Protein,kappa B-like site,O
67,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,41,55,non_Protein,nuclear complex,119,133,non_Protein,5'-CGGAGTTTCC-3,O
68,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,41,55,non_Protein,nuclear complex,144,161,non_Protein,5'-flanking region,O
69,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,41,55,non_Protein,nuclear complex,176,177,Protein,TF,O
70,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,100,116,non_Protein,kappa B-like site,119,133,non_Protein,5'-CGGAGTTTCC-3,O
71,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,100,116,non_Protein,kappa B-like site,144,161,non_Protein,5'-flanking region,O
72,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,100,116,non_Protein,kappa B-like site,176,177,Protein,TF,Protein-Component
73,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,119,133,non_Protein,5'-CGGAGTTTCC-3,144,161,non_Protein,5'-flanking region,O
74,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,119,133,non_Protein,5'-CGGAGTTTCC-3,176,177,Protein,TF,Protein-Component
75,"Here we report the characterization of a nuclear complex from human monocytic cells that bound to a kappa B-like site, 5'-CGGAGTTTCC-3', in the 5'-flanking region of the human TF gene.",14,2268,144,161,non_Protein,5'-flanking region,176,177,Protein,TF,Protein-Component
76,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,50,53,non_Protein,site,O
77,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,72,76,Protein,c-Rel,O
78,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,82,84,Protein,p65,O
79,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,86,95,non_Protein,homodimers,O
80,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,105,124,non_Protein,p50/p65 heterodimers,O
81,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,129,131,Protein,p50,O
82,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,47,48,Protein,TF,133,142,non_Protein,homodimers,O
83,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,72,76,Protein,c-Rel,Protein-Component
84,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,82,84,Protein,p65,O
85,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,86,95,non_Protein,homodimers,O
86,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,105,124,non_Protein,p50/p65 heterodimers,O
87,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,129,131,Protein,p50,O
88,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,50,53,non_Protein,site,133,142,non_Protein,homodimers,O
89,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,72,76,Protein,c-Rel,82,84,Protein,p65,O
90,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,72,76,Protein,c-Rel,86,95,non_Protein,homodimers,Subunit-Complex
91,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,72,76,Protein,c-Rel,105,124,non_Protein,p50/p65 heterodimers,O
92,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,72,76,Protein,c-Rel,129,131,Protein,p50,O
93,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,72,76,Protein,c-Rel,133,142,non_Protein,homodimers,O
94,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,82,84,Protein,p65,86,95,non_Protein,homodimers,Subunit-Complex
95,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,82,84,Protein,p65,105,124,non_Protein,p50/p65 heterodimers,O
96,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,82,84,Protein,p65,129,131,Protein,p50,O
97,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,82,84,Protein,p65,133,142,non_Protein,homodimers,O
98,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,86,95,non_Protein,homodimers,105,124,non_Protein,p50/p65 heterodimers,O
99,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,86,95,non_Protein,homodimers,129,131,Protein,p50,O
100,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,86,95,non_Protein,homodimers,133,142,non_Protein,homodimers,O
101,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,105,124,non_Protein,p50/p65 heterodimers,129,131,Protein,p50,O
102,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,105,124,non_Protein,p50/p65 heterodimers,133,142,non_Protein,homodimers,O
103,In vitro binding studies demonstrated that the TF site bound translated c-Rel and p65 homodimers but not p50/p65 heterodimers or p50 homodimers.,16,2549,129,131,Protein,p50,133,142,non_Protein,homodimers,Subunit-Complex
104,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,34,37,non_Protein,site,Protein-Component
105,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,72,79,non_Protein,cytosine,O
106,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,84,93,non_Protein,position 1,O
107,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,116,125,non_Protein,NF-kappa B,O
108,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,178,179,Protein,TF,O
109,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,181,187,non_Protein,complex,O
110,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,221,234,non_Protein,p50/p65 dimers,O
111,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,31,32,Protein,TF,264,279,non_Protein,c-Rel/p65 dimers,O
112,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,72,79,non_Protein,cytosine,O
113,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,84,93,non_Protein,position 1,O
114,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,116,125,non_Protein,NF-kappa B,O
115,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,178,179,Protein,TF,O
116,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,181,187,non_Protein,complex,O
117,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,221,234,non_Protein,p50/p65 dimers,O
118,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,34,37,non_Protein,site,264,279,non_Protein,c-Rel/p65 dimers,O
119,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,84,93,non_Protein,position 1,O
120,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,116,125,non_Protein,NF-kappa B,O
121,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,178,179,Protein,TF,O
122,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,181,187,non_Protein,complex,O
123,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,221,234,non_Protein,p50/p65 dimers,O
124,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,72,79,non_Protein,cytosine,264,279,non_Protein,c-Rel/p65 dimers,O
125,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,84,93,non_Protein,position 1,116,125,non_Protein,NF-kappa B,O
126,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,84,93,non_Protein,position 1,178,179,Protein,TF,O
127,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,84,93,non_Protein,position 1,181,187,non_Protein,complex,O
128,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,84,93,non_Protein,position 1,221,234,non_Protein,p50/p65 dimers,O
129,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,84,93,non_Protein,position 1,264,279,non_Protein,c-Rel/p65 dimers,O
130,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,116,125,non_Protein,NF-kappa B,178,179,Protein,TF,O
131,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,116,125,non_Protein,NF-kappa B,181,187,non_Protein,complex,O
132,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,116,125,non_Protein,NF-kappa B,221,234,non_Protein,p50/p65 dimers,O
133,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,116,125,non_Protein,NF-kappa B,264,279,non_Protein,c-Rel/p65 dimers,O
134,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,178,179,Protein,TF,181,187,non_Protein,complex,Subunit-Complex
135,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,178,179,Protein,TF,221,234,non_Protein,p50/p65 dimers,O
136,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,178,179,Protein,TF,264,279,non_Protein,c-Rel/p65 dimers,O
137,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,181,187,non_Protein,complex,221,234,non_Protein,p50/p65 dimers,O
138,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,181,187,non_Protein,complex,264,279,non_Protein,c-Rel/p65 dimers,O
139,"Base-pair substitutions in the TF site indicated that the presence of a cytosine at position 1 precluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.",17,2694,221,234,non_Protein,p50/p65 dimers,264,279,non_Protein,c-Rel/p65 dimers,O
140,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,105,109,Protein,c-Rel,O
141,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,115,117,Protein,p65,O
142,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,138,140,Protein,p50,O
143,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,149,150,Protein,TF,O
144,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,152,158,non_Protein,complex,O
145,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,184,205,non_Protein,c-Rel/p65 heterodimers,O
146,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,232,233,Protein,TF,O
147,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,23,32,non_Protein,NF-kappa B,235,251,non_Protein,kappa B-like site,O
148,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,115,117,Protein,p65,O
149,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,138,140,Protein,p50,O
150,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,149,150,Protein,TF,O
151,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,152,158,non_Protein,complex,O
152,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,184,205,non_Protein,c-Rel/p65 heterodimers,O
153,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,232,233,Protein,TF,O
154,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,105,109,Protein,c-Rel,235,251,non_Protein,kappa B-like site,O
155,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,138,140,Protein,p50,O
156,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,149,150,Protein,TF,O
157,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,152,158,non_Protein,complex,O
158,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,184,205,non_Protein,c-Rel/p65 heterodimers,O
159,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,232,233,Protein,TF,O
160,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,115,117,Protein,p65,235,251,non_Protein,kappa B-like site,O
161,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,138,140,Protein,p50,149,150,Protein,TF,O
162,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,138,140,Protein,p50,152,158,non_Protein,complex,O
163,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,138,140,Protein,p50,184,205,non_Protein,c-Rel/p65 heterodimers,O
164,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,138,140,Protein,p50,232,233,Protein,TF,O
165,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,138,140,Protein,p50,235,251,non_Protein,kappa B-like site,O
166,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,149,150,Protein,TF,152,158,non_Protein,complex,Subunit-Complex
167,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,149,150,Protein,TF,184,205,non_Protein,c-Rel/p65 heterodimers,O
168,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,149,150,Protein,TF,232,233,Protein,TF,O
169,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,149,150,Protein,TF,235,251,non_Protein,kappa B-like site,O
170,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,152,158,non_Protein,complex,184,205,non_Protein,c-Rel/p65 heterodimers,O
171,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,152,158,non_Protein,complex,232,233,Protein,TF,O
172,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,152,158,non_Protein,complex,235,251,non_Protein,kappa B-like site,O
173,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,184,205,non_Protein,c-Rel/p65 heterodimers,232,233,Protein,TF,O
174,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,184,205,non_Protein,c-Rel/p65 heterodimers,235,251,non_Protein,kappa B-like site,O
175,Antibodies against the NF-kappa B and Rel proteins and UV cross-linking studies revealed the presence of c-Rel and p65 and the absence of p50 in the TF complex and further showed that c-Rel/p65 heterodimers selectively bound to the TF kappa B-like site.,18,2976,232,233,Protein,TF,235,251,non_Protein,kappa B-like site,Protein-Component
176,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,38,39,Protein,TF,41,44,non_Protein,site,Protein-Component
177,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,38,39,Protein,TF,78,98,non_Protein,heterologous promoter,O
178,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,38,39,Protein,TF,126,130,Protein,c-Rel,O
179,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,38,39,Protein,TF,135,137,Protein,p65,O
180,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,41,44,non_Protein,site,78,98,non_Protein,heterologous promoter,O
181,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,41,44,non_Protein,site,126,130,Protein,c-Rel,O
182,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,41,44,non_Protein,site,135,137,Protein,p65,O
183,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,78,98,non_Protein,heterologous promoter,126,130,Protein,c-Rel,O
184,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,78,98,non_Protein,heterologous promoter,135,137,Protein,p65,O
185,Functional studies indicated that the TF site conferred LPS inducibility on a heterologous promoter and was transactivated by c-Rel or p65.,19,3230,126,130,Protein,c-Rel,135,137,Protein,p65,O
186,"Taken together, our results demonstrated that binding of c-Rel/p65 heterodimers to a novel kappa B-like site mediated LPS induction of TF gene expression in monocytic cells.",20,3370,57,78,non_Protein,c-Rel/p65 heterodimers,91,107,non_Protein,kappa B-like site,O
187,"Taken together, our results demonstrated that binding of c-Rel/p65 heterodimers to a novel kappa B-like site mediated LPS induction of TF gene expression in monocytic cells.",20,3370,57,78,non_Protein,c-Rel/p65 heterodimers,135,136,Protein,TF,O
188,"Taken together, our results demonstrated that binding of c-Rel/p65 heterodimers to a novel kappa B-like site mediated LPS induction of TF gene expression in monocytic cells.",20,3370,91,107,non_Protein,kappa B-like site,135,136,Protein,TF,Protein-Component
